SONOVA Hldg AG/ADR (OTCMKTS:SONVY) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a note issued to investors on Saturday. The brokerage presently has a $47.00 price target on the stock. Zacks Investment Research‘s price target suggests a potential upside of 16.28% from the stock’s previous close.

According to Zacks, “Sonova Holding AG is a manufacturer of hearing care solutions. The company’s operating business brands consists of Phonak, Unitron, Advanced Bionics and AudioNova. Its product portfolio consists of hearing instruments and cochlear implants to wireless communication solutions. Sonova Holding AG is headquartered in Stäfa, Switzerland. “

OTCMKTS:SONVY opened at $40.42 on Friday. SONOVA Hldg AG/ADR has a 52-week low of $29.79 and a 52-week high of $42.02.

SONOVA Hldg AG/ADR Company Profile

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name.

Featured Article: Understanding Average Daily Trade Volume

Get a free copy of the Zacks research report on SONOVA Hldg AG/ADR (SONVY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for SONOVA Hldg AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SONOVA Hldg AG/ADR and related companies with MarketBeat.com's FREE daily email newsletter.